Kara Bickham

Kara Bickham has a diverse work experience spanning over several years. Kara is currently serving as the Vice President of Clinical Research and Development at Pfizer. Prior to this, they held the role of Member at Chief. From 2021 to 2022, Kara worked as the Chief Medical Officer at Affinivax Inc., where they played a crucial role in setting goals, strategy alignment, pipeline development, and medical input to drug discovery and pre-clinical development activities.

Before joining Affinivax Inc., Kara held multiple positions at Merck from 2014 to 2021, including Executive Director, Senior Principal Scientist in Vaccines Clinical Research, Senior Principal Scientist in Respiratory & Immunology Clinical Research, and Principal Scientist in Clinical Research. Kara made significant contributions to the company's clinical research and development efforts during their tenure.

Kara's early career included roles as an Editorial Reviewer and Consultant at RIKEN, where they worked on tumor immunology research, and as an Associate Research Scientist at Columbia University in the City of New York.

Furthermore, they worked as a General Pediatrician at Gergely Pediatrics, conducting patient care in the field of pediatrics. Kara also gained research experience as a Research Associate and Postdoctoral Research Fellow at Rockefeller University.

Kara completed their medical training at Weill Cornell Medical College, where they served as a Pediatric Infectious Diseases Fellow, Pediatric Resident, and Pediatric Intern.

Overall, Kara Bickham's work experience showcases their expertise in clinical research, medical leadership, and pediatric care across various prestigious institutions and organizations.

Kara Bickham holds a Doctor of Medicine (M.D.) degree in Medicine from UT Southwestern Medical Center. Kara also obtained a Certificate in Advanced Vaccinology Course from the University of Geneva in 2021. Additionally, Kara holds a Bachelor's Degree in Neuroscience from Texas Christian University.